Steven Cohen Morphic Holding, Inc. Transaction History
Point72 Asset Management, L.P.
- $39.3 Billion
- Q1 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 4,687,100 shares of MORF stock, worth $160 Million. This represents 0.42% of its overall portfolio holdings.
Number of Shares
4,687,100
Previous 4,591,000
2.09%
Holding current value
$160 Million
Previous $133 Million
24.43%
% of portfolio
0.42%
Previous 0.33%
Shares
13 transactions
Others Institutions Holding MORF
# of Institutions
142Shares Held
37.9MCall Options Held
13.5KPut Options Held
190K-
Wellington Management Group LLP Boston, MA4.02MShares$137 Million0.03% of portfolio
-
Black Rock Inc. New York, NY3.28MShares$112 Million0.0% of portfolio
-
State Street Corp Boston, MA2.67MShares$90.8 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.52MShares$86 Million0.01% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA2.38MShares$81.2 Million2.39% of portfolio
About Morphic Holding, Inc.
- Ticker MORF
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,477,100
- Market Cap $1.31B
- Description
- Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...